Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference96 articles.
1. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma;Crawford;New England Journal of Medicine,1989
2. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy;Geller;Journal of Urology,1984
3. Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?;Perachino;BJU International,2010
4. Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen;Narimoto;International Journal of Urology,2010
5. van der Sluis TM, Vis AN, van Moorselaar RJ, et al. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer. BJU International, 2011, http://dx.doi.org/10.1111/j.1464-410X.2011.10651.x [Epub ahead of print].
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?;Andrology;2023-09-26
2. Neoadjuvant androgen deprivation therapy combined with abiraterone acetate in patients with locally advanced or metastatic prostate cancer: When to perform radical prostatectomy?;Cancer Medicine;2022-09-15
3. Biological roles and clinical significance of estrogen and androgen receptors in head and neck cancers;Journal of Cancer;2022
4. miRNAs and androgen deprivation therapy for prostate cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12
5. Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes;Cancers;2021-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3